Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human melanoma metastases express functional CXCR4.

Stefania Scala1, Paola Giuliano, Paolo A Ascierto

  • 1Department of Clinical Immunology, National Cancer Institute, G. Pascale Foundation, Naples, Italy.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 28, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Histopathologic and Targeted Genomic Characterization of Gastric Adenocarcinomas with Yolk Sac Tumor Differentiation.

International journal of molecular sciences·2026
Same author

Non-invasive cell-free DNA-based approach for the diagnosis of aneuploidies in spontaneous abortion.

Fetal diagnosis and therapy·2026
Same author

Oligometastatic versus polymetastatic colon cancer: functional and genomic determinants of divergent metastatic trajectories.

Exploration of targeted anti-tumor therapy·2026
Same author

Feasibility Assessment of Telehealth-Based Cancer Pain Management Through Machine Learning: A Prospective Clinical Study.

Pain research & management·2026
Same author

Genomic profiling of a DICER1-wildtype thyroblastoma reveals AGK-BRAF fusion, EIF1AX duplication, and TERT promoter mutations: integrated genomic and pathway analysis.

Frontiers in endocrinology·2026
Same author

Imaging and AI in tertiary prevention of lung cancer: Narrative review and clinical perspectives.

Multidisciplinary respiratory medicine·2026

Chemokine receptor CXCR4 is active in melanoma metastases, promoting cell growth and migration. Inhibitors like AMD3100 show potential for treating this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • CXCR4 is a chemokine receptor implicated in cancer progression.
  • Previous studies identified CXCR4 as a predictor of poor prognosis in primary melanoma.

Purpose of the Study:

  • To investigate the role and function of CXCR4 in human melanoma metastases.
  • To assess the therapeutic potential of CXCR4 inhibitors in melanoma.

Main Methods:

  • Evaluated CXCR4 expression in melanoma metastases and cell lines using immunohistochemistry, immunoblotting, immunofluorescence, and RT-PCR.
  • Assessed CXCR4 function by measuring Erk-1/Erk-2 phosphorylation, proliferation, apoptosis, and migration in response to CXCL12.
  • Utilized AMD3100, a CXCR4 inhibitor, to block CXCL12-induced effects.

Related Experiment Videos

Main Results:

  • CXCR4 was detected in 52.4% of melanoma metastases and expressed on metastatic melanoma cell lines.
  • CXCL12 (ligand) activated Erk-1/Erk-2 phosphorylation, enhanced cell proliferation, and promoted migration.
  • AMD3100 inhibited CXCL12-induced proliferation and migration, but not apoptosis.

Conclusions:

  • CXCR4 is expressed and functionally active in human melanoma metastases.
  • Targeting CXCR4 with inhibitors like AMD3100 may represent a viable therapeutic strategy for melanoma.